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Abstract
Release of chemotactic factors in response to tissue 
damage has been described for different musculoskeletal 
tissues, including the intervertebral disc (IVD). This 
study investigated the chemoattractants that are released 
by induced degenerative IVDs and may be involved 
in recruiting mesenchymal stem cells (MSCs). Bovine 
caudal discs were cultured within a bioreactor and 
loaded under conditions that mimicked physiological 
or degenerative settings. Between days 4-6, medium 
was replaced by PBS, which was subsequently used for 
proteomic, ELISA and immunoprecipitation analyses of 
secreted chemokines and cytokines. A Boyden chamber 
assay was used to observe human MSC migration towards 
native and chemokine depleted media. Gene expression 
levels of chemokine receptors in human MSCs were 
analysed, and CCL5 was localised in bovine and human 
IVD by immunohistochemistry. Proteomic analysis 
revealed the presence of CCL5 and CXCL6 within 
conditioned media. Higher concentrations of CCL5 were 
found in the degenerative media, and a relationship was 
found between interleukin-1β and CCL5 concentration. 
Chemokine immunoprecipitation showed that MSCs had 
a significantly reduced chemotactic migration towards 
CCL5-immunoprecipitated and CCL5/CXCL6 co-
immunoprecipitated media, whilst CXCL6 depletion did 
not change MSC chemotaxis. MSCs showed a significant 
increase in mRNA expression of the CCL5 receptors, 
CCR1 and CCR4, upon culture in degenerative media. 
Furthermore, CCL5 was identified in bovine and human 
disc tissue by immunohistochemistry. Hence, CCL5 may 
be a key chemoattractant that is produced and released by 
the intervertebral disc cells. Therefore, these factors could 
be used to enhance stem/progenitor cell mobilisation in 
regenerative therapies for early stages of disc degeneration.
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Introduction
Effective treatment of intervertebral disc (IVD) 
degeneration is an unmet medical need that requires 
strategies for repair due to its inherent poor repair 
capacity. In the early stages of degeneration, minimally 
invasive biological repair strategies could aid in the IVD 
regeneration, such as injectable scaffolds, biomaterials 
and cell based therapies (Hiyama et al., 2008; Yang 
and Li, 2009; Collin et al., 2011; Peroglio et al., 2012). 
Furthermore, there has been great interest in developing 
new therapeutic techniques such as the use of growth 
factors, mesenchymal stem cells (MSCs), or delivery 
of therapeutic genes via cellular transduction (Serigano 
et al., 2010; Orozco et al., 2011; Zhang et al., 2011). 
However, it is still uncertain which type of cell, biologics 
or gene therapy would induce the greatest sustained effect. 
Additionally, in the cases of growth factors and/or MSCs, 
their administration could induce an undesired response 
such as ossification within the damaged area (Huang et 
al., 2007; Vadala et al., 2012). A cellular response that 
could induce a sustained therapeutic effect is stem or 
progenitor cell homing. Stem or progenitor cell homing 
generally occurring following injury has been described 
for different musculoskeletal tissues and has also been 
demonstrated for induced degenerative disc tissue ex vivo 
(Lee et al., 2010a; Shinohara et al., 2011; Illien-Junger et 
al., 2012; Seol et al., 2012).
 Homing of stem or progenitor cells may be described 
as the activation of an endogenous mechanism for tissue 
regeneration. This process has been documented in 
vivo, whereby systemic MSC injection resulted in the 
migration of cells towards the site of injury due to the 
presence of chemokine/chemoattractant signals (Karp 
and Leng Teo, 2009; Fong et al., 2011). The process of 
cell migration is controlled by a group of cell-signalling 
molecules, including inflammatory cytokines that 
accelerate degeneration (e.g. tumour necrosis factor-alpha 
(TNF-α) and interleukin-1 beta (IL-1β)) and molecules 
that enable cell migration/chemotaxis to occur (e.g., 
stromal cell derived factor-1 (SDF-1) and monocyte 
chemotactic protein-1 (MCP-1)). This latter sub-group 
of cell-signalling molecules are known as chemokines. 
It is believed that the release of inflammatory cytokines 
during degeneration results in the production of various 
chemokines. Besides the chemokines, molecules that 
induce chemotaxis or chemically induced migration also 
include various growth factors, such as insulin-like growth 
factor-1 (IGF-1), transforming growth factor-β (TGF-β), 
platelet derived growth factor (PDGF), and fibroblast 
CCL5/RANTES IS A KEY CHEMOATTRACTANT RELEASED BY DEGENERATIVE 
INTERVERTEBRAL DISCS IN ORGAN CULTURE
G. Pattappa1, M. Peroglio1, D. Sakai2, J. Mochida2, L.M. Benneker3, M. Alini1 and S. Grad1,*
1AO Research Institute, Davos, Switzerland
 2Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine, Isehara,
Kanagawa, Japan
 3Department of Orthopaedic Surgery, University of Bern, Bern, Switzerland
125 www.ecmjournal.org
G Pattappa et al.                                                                                 CCL5/RANTES is released by intervertebral disks
growth factor -2 (FGF-2) (Ponte et al., 2007; Lazennec 
and Richmond, 2010; Ito, 2011).
 Studies observing the chemotactic migration of MSCs 
using various chemoattractants showed that IGF-1, TGF-β, 
SDF-1 and FGF-2 induced chemoattraction of MSCs 
(Fiedler et al., 2002; Fiedler et al., 2004; Ozaki et al., 
2007; Ponte et al., 2007; Lee et al., 2010b; Baek et al., 
2011). Treatment of MSCs with TNF-α helped increase 
the responsiveness of MSCs towards both growth factors 
(PDGF, TGF-β and IGF-1) and chemokines (SDF-1, 
MCP-1, and CCL5/RANTES (Regulated upon Activation, 
Normal T-cell Expressed, and Secreted)) (Ozaki et al., 
2007; Ponte et al., 2007; Baek et al., 2011). The results 
of TNF-α priming studies indicate that the degenerative 
state has an influence on cellular migration towards injury 
sites (Ponte et al., 2007). This may be due to the increased 
expression and responsiveness of the cell surface receptors 
that facilitate the chemotactic process. Chemokine 
receptors can be divided into two groups, the CXC and 
CC receptors. These receptors interact with different 
chemokines from their respective families, e.g., CXCR4 for 
CXCL12, which is homologous to SDF-1, and CCR1/3/4/5 
for CCL5 (Ben-Baruch et al., 1995; Honczarenko et al., 
2006).
 Recently, we have shown that bone marrow derived 
MSCs can migrate into induced degenerative intervertebral 
discs following organ culture in an ex vivo bioreactor 
system (Illien-Junger et al., 2012). Data also indicated 
that MSC migration was related to the presence of 
chemokines and chemoattractants that are released by the 
disc cells. However, the factors that specifically induce 
this process need to be identified in order to understand 
how homing may occur within the intervertebral disc and 
to develop strategies that could induce or accelerate this 
process. Therefore, the aim of this study was to identify 
the chemoattractant(s) that enable MSC homing into 
the intervertebral disc. Proteomic, gene expression and 
functional cell migration techniques were used to examine 
the factors that are produced by induced degenerative discs 
and would facilitate migration of MSCs towards the site 
of damage.
Materials and Methods
Induction of IVD degeneration using an ex vivo 
bioreactor system
Intervertebral discs were excised from 5-8 month old 
bovine tails obtained from a local abattoir. Briefly, discs 
were excised with intact distal and proximal end-plates 
and rinsed in phosphate buffered saline (PBS) containing 
1000 units/mL penicillin and 1000 μg/mL streptomycin. 
A jet lavage system (Zimmer, Winterthur, Switzerland) 
was used to clean the end-plates from debris, and discs 
were further washed using PBS containing 1000 units/
mL penicillin and 1000 μg/mL streptomycin. The discs 
(mean diameter: 11.8 ±0.9 mm) were cultured within a 
bioreactor system under simulated physiological or induced 
degenerative conditions (Illien-Junger et al., 2012). In 
brief, “simulated physiological” conditions comprised 
of discs cultured in Dulbecco’s modified Eagle Medium 
(DMEM) containing 4.5 g/L glucose + 1 % ITS+1 + 0.1 % 
Primocin (all Sigma-Aldrich, Poole, UK) and loaded at a 
frequency of 0.2 Hz (0.6 ±0.2 MPa) during seven days (low 
frequency; LF). “Induced degenerative” discs were initially 
punched with a 22-gauge needle and then fed DMEM + 
4.5 g/L glucose + 1 % ITS+1 + 0.1 % Primocin. Discs 
were loaded at a frequency of 10 Hz under the previously 
described loading parameters (high frequency; HF). 
Medium was replenished from the discs on days 1, 3, 5 
and 7. Spent media from days 3, 5 and 7 were stored frozen 
for chemotaxis analysis using a Boyden chamber assay.
 In separate experiments, “simulated physiological” 
discs were cultured as described above, while “induced 
degenerative” discs were punched with a 22-gauge 
needle, fed DMEM + 2 g/L glucose + 1 % ITS+1 + 0.1 % 
Primocin, and loaded at a frequency of 10 Hz under the 
previously described loading parameters (low glucose and 
high frequency; HF). Reduced glucose condition has been 
shown to further increase the degenerative state of the IVD 
ex vivo (Illien-Junger et al., 2010). Medium was removed 
on day 4 and replaced with 2.5 mL PBS + 4.5 g/L glucose 
for each disc condition with loading parameters remaining 
the same. PBS was removed after two days and then used 
for subsequent proteomic, ELISA and chemotaxis analysis.
 A summary of the experimental settings, sample types 
and outcome parameters used for this study is shown in 
Table 1.
Chemotaxis analysis
Chemotaxis studies required the use of human bone marrow 
derived mesenchymal stem cells (MSCs) that were isolated 
using Ficoll gradient procedure as previously described (Li 
et al., 2009). Bone marrow aspirates from vertebral bone or 
iliac crest were obtained from the University Hospital Bern 
after ethical approval and informed consent (KEK 188/10). 
Second passage cells (P2) were used for all experiments.
 Chemotaxis analysis was performed on medium 
samples recovered from each of the time points described 
(n = 6 media from different animals per time point). The 
bottom Boyden chamber (Neuroprobe, Gothenburg, 
Sweden) had media from degenerative disc mixed 
with media from physiological disc to produce a range 
of media concentrations (100 % degenerative; 75 % 
degenerative + 25 % physiological; 25 % degenerative 
+ 75 % physiological; 100 % physiological media) that 
were arranged in columns in the chamber. A polycarbonate 
membrane (25 x 80 mm membrane: 8 μm pores; 
Neuroprobe) was applied to this chamber and then a top 
chamber was placed on to the membrane. Passage 2 MSCs 
from a 41 year old male donor were suspended in each of 
the medium concentrations described above and added 
in rows along the top chamber – each row representing a 
medium concentration. Each well contained 2 x 104 MSCs. 
The chamber was incubated at 37 °C for six hours to enable 
cell migration to occur.
 The membrane was cleaned using a wiper blade to 
remove non-migrated cells, fixed with methanol and 
then stained using toluidine blue. The membrane was 
mounted on a glass slide and imaged using a motorised 
microscope at x5 magnification (Axiovert 200m; Zeiss, 
Jena, Germany). The cells were interactively marked and 
blind counted for chemotaxis analysis.
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Proteomics
Day 4-6 PBS media samples (n = 4 media from different 
animals) were lyophilised in preparation for proteomics. 
The analysis of these samples was performed by the 
Proteomics Core Facility and Biomedical Proteomics 
research group, University of Geneva as described by 
Dayon et al. (Dayon et al., 2008; Dayon et al., 2011). 
TMT® isobaric mass tagging (Thermo Scientific, Rockford, 
IL, USA) was utilised to identify the peptides belonging 
to specific proteins. TMT mass tags labelled the intact 
proteins and then a fractionation process was utilised prior 
to mass spectroscopy analysis. LC-MS/MS was performed 
on a linear trap quadrupole (LTQ) Orbitrap Velos (Thermo 
Electron, San Jose, CA, USA) and peptide analysis was 
performed for identification of peptide sequences using 
Scaffold 3.0 (Proteome Software, Portland, OR, USA) as 
previously described and displayed (Epiney et al., 2012).
Chemokine gene expression
Whole discs from the day of harvest (day 0) and discs 
cultured for 2, 4 or 7 days under physiological and 
degenerative culture conditions were initially placed in 
RNAlater (Sigma-Aldrich) and stored at 4 °C prior to use 
(n = 4-6 discs per group from different animals). Nucleus 
pulposus (NP) and annulus fibrosus (AF) tissues were 
separated using a 5 mm punch (Kai Medical, Japan). NP 
and AF samples were then flash frozen in liquid nitrogen 
and pulverised using a tissue lyser (Qiagen, West Sussex, 
UK). RNA was extracted using a modified TRI-spin 
method with TRI Reagent (Molecular Research Centre, 
Cincinatti, OH, USA) and a total RNA extraction kit 
(Machery-Nagel, Duren, Germany). Reverse transcription 
was performed using SuperScript® VILO™ cDNA 
Synthesis Kit (Invitrogen, Carlsbad, CA, USA). The 
following Gene Expression Assays (all from Applied 
Biosystems, Foster City, CA, USA) were used to quantify 
the mRNA expression of the chemokines identified from 
the proteomics study: CCL5/RANTES (Bt03216832_m1) 
and CXCL6 (Bt03259300_m1). The expression level of the 
well characterised chemokine, CXCL12 (Bt03276322_m1) 
was also measured. The real-time PCR was performed 
using the Step One Plus Real time PCR system (Applied 
Biosystems). Relative quantification of target mRNA was 
performed using the ΔCT method with 18S rRNA used 
for data normalisation (18S ribosomal RNA (Applied 
Biosystems Cat. No. 431089E)).
ELISA assay
The concentrations of specific chemoattractants identified 
in the proteomic analysis were investigated in the 
physiological and degenerative conditioned media. PBS 
medium samples from each condition taken between 
days 4-6 were utilised for this study (n = 6-8 media from 
different animals). The proteins investigated were bovine 
CCL5/RANTES and bovine CXCL6, alongside the 
inflammatory cytokines, IL-1β and TNF-α. All ELISAs 
were obtained from Hoelzel Diagnostika (Cologne, 
Germany) and performed according to manufacturer’s 
instructions.
Immunoprecipitation of chemoattractants
PBS conditioned degenerative disc medium was 
immunoprecipitated against specific chemoattractants 
that were found following the proteomics study (n = 6 
media from different animals). Antibodies against CCL5/
RANTES and CXCL6 (SRB laboratories, Aachen, 
Germany) were utilised. Each antibody was added to 
samples of PBS media at 1 μg/mL, including a sample 
containing both antibodies. The samples were incubated 
at 4 °C with continuous shaking for one hour. Following 
incubation, one re-suspended volume of Protein G PLUS-
Agarose beads (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) was added to each sample and then incubated 
overnight at 4 °C with shaking. Conditioned PBS media 
samples with only beads present were also formulated 
to determine potential unspecific binding of chemotactic 
proteins.
 A Boyden chamber assay was performed with 
medium arranged in rows in the bottom chamber 
representing the immunoprecipitated samples (CXCL6 
immunoprecipitated out, CCL5 precipitated out and 
CXCL6/CCL5 immunoprecipitated out) and the untreated 
sample. The corresponding physiologically conditioned 
PBS sample containing MSCs from a 40 year old female 
Experiment 
setting IVD culture conditions Samples and time points Outcome parameters
1
a) Low frequency – 
high glucose for 7 days 
b) High frequency – 
high glucose for 7 days
Conditioned media: 
d 3, d 5, d 7 MSC chemotaxis
Total RNA: 
d 2, d 4, d 7 Chemokine gene expression
Whole IVD: 
d 7 Immunohistochemistry
2
a) Low frequency – 
high glucose for 4 days 
+ low frequency – 
PBS for 2 days
b) High frequency – 
low glucose for 4 days 
+ high frequency – 
PBS for 2 days
Conditioned PBS media: 
d 6
•	 Proteomics
•	 ELISA
•	 Chemokine immuno-precipitation 
and MSC chemotaxis
•	 MSC chemokine receptor gene 
expression
Table 1. Summary of the experimental settings of bovine IVD culture conditions, types and time points 
of samples, and corresponding outcome parameters.
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donor was arranged in the top chamber and incubated and 
analysed as described above.
MSC chemokine receptor response upon culture in 
degenerative and physiological media
Passage 2 MSCs from a 47 year old male donor were 
seeded at 0.5 x 105 cells per well in a 48-well plate in 
DMEM/10 % FCS and allowed to attach overnight. 
Medium was replenished from each well, replaced with 
200 μL PBS conditioned physiological and degenerative 
media (n = 6 media from different animals) and incubated 
for 12 h. RNA was extracted from the cells using TRI 
reagent, and cDNA synthesis was performed using 
SuperScript® VILO™ cDNA Synthesis Kit. Real time 
PCR analysis was performed as described above. The 
genes analysed for this investigation were the chemokine 
receptors CCR1 (Hs00928897_s1), CCR3 (Hs00266213_
s1), CCR4 (Hs00747615_s1), CCR5 (Hs99999149_s1) and 
CXCR1 (Hs01921207_s1) (all Gene Expression Assays 
from Applied Biosystems).
Immunohistochemistry
After 7 days of culture under physiological or under 
degenerative conditions, bovine discs were fixed with 
formalin, decalcified, embedded in paraffin, and cut 
sagittally into 6 µm sections. Following de-waxing and 
rehydration, antigen retrieval was performed by treating 
sections with citrate buffer (10 mM sodium citrate, 0.05 % 
Tween 20, pH 6.0) for 15 min, and then endogenous 
peroxidases were quenched using 3 % hydrogen peroxide 
in methanol for 30 min. Sections were blocked with 
goat serum (1:200, Vector Laboratories) for 1 h at room 
temperature and then incubated overnight at 4 °C with 
rabbit polyclonal anti-CCL5/RANTES antibody (1:200, 
Bioss cat.nr. bs-1324R, Woburn, MA, USA) plus goat 
serum (1:200). For the negative control, the primary 
antibody was replaced by PBS. Following wash steps, 
sections were incubated with biotinylated anti-rabbit 
antibody (1:200) for 30 min, and binding was detected 
using diaminobenzidine (DAB) detection system (all 
products by Vector laboratories). The sections were 
visualised under transmitted light using an upright optical 
microscope (Axioplan 2, Zeiss). Images were obtained 
using a 20x objective with a constant acquisition time for 
all sections (200 ms).
 Surgical samples were obtained after informed consent 
from seven patients who required anterior fusion surgery 
due to trauma or degeneration (Inselspital, University of 
Bern, Switzerland). Pre-operative computer tomograms 
(CT scans) allowed for a modified composite radiographic 
score for disc degeneration (Benneker et al., 2005). Four 
samples (average age 25.5 ±3.0 years) were graded 1/5-
2/5; three samples (average age 38.7 ±4.7 years) were 
graded 3/5-4/5. Samples were formalin fixed, embedded 
in paraffin and cut into 6 µm thin sections in the transverse 
plane. Sections were processed and visualised as described 
above for the bovine samples, using rabbit polyclonal 
anti-CCL5/RANTES antibody (2 µg/mL, Abcam cat.nr. 
ab9679, Cambridge, UK) for immunolabelling.
Statistical analysis
SPSS 19 software was used for statistical analysis (SPSS, 
Chicago, IL, USA). Non parametric analysis was used for 
non-symmetrically distributed data sets. Gene expression 
values of bovine NP and AF cells were normalised to the 
day 0 NP and AF values and log10 transformed. Expression 
differences between groups (NP-LF, NP-HF, AF-LF, AF-
HF) were then analysed using the Kruskal-Wallis test and 
pairwise comparisons after exclusion of outliers for each 
time point. Expression differences between cells from 
cultured discs and the day 0 NP and AF values, respectively, 
were analysed using Mann-Whitney-U test (Fig. 2). 
Univariate analysis of variance (ANOVA) and Games-
Howell post-hoc test was used to analyse differences in 
cell migration towards different medium concentrations 
(Fig. 1) and towards differently treated media (Fig. 4a). 
Differences in chemokine and cytokine concentrations 
between degenerative and physiological media (Figs. 3a-d) 
and gene expression differences between MSCs cultured 
in degenerative and physiological medium (Fig. 4b) were 
analysed using t-tests. Trends between cytokines and 
chemokines were analysed using Spearman’s correlation 
co-efficient. A p ≤ 0.05 was observed to have significant 
differences, and a statistical trend was defined as p < 0.1.
Results
Chemoattractants are released from bovine IVDs 
during organ culture
Chemotactic analysis of media samples from degenerative 
discs demonstrated that chemoattractants were released 
from the tissue at each time point investigated. MSCs were 
attracted towards increasing concentrations of degenerative 
media collected at days 3, 5 and 7. There was no significant 
difference in MSC migration towards 100 % degenerative 
medium between each time point measured. However, 
at each time point, there was found to be a significant 
difference between the media concentrations, specifically 
with respect to migration from 100 % physiological 
medium in the upper chamber (Fig. 1; p < 0.05).
Proteomics shows the presence of chemoattractants 
in conditioned medium
Proteomic analysis of the degenerative and physiological 
media samples identified the presence of 104 proteins 
in either physiological or degenerative media (Table 2). 
The proteomic analysis demonstrated the presence of two 
chemoattractants, CCL5 (RANTES) and CXCL6 (GCP-2), 
in both physiological and degenerative medium samples. 
Further analyses focussed on the role of CCL5 and CXCL6 
on the migration of MSCs.
Chemokine gene expression is differently regulated 
in cultured IVD
mRNA expression levels of the two identified chemokines, 
CCL5 and CXCL6 were determined in addition to the 
well-established chemokine, CXCL12. In relation to 
day 0 mRNA expression, CCL5 mRNA demonstrated 
a significant increase in expression for NP under 
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Protein
Relative 
intensity ratio 
between 
media (LF/HF)
Alpha-2-macroglobulin 0.94
Aggrecan core protein 0.92
Actin, cytoplasmic 1.14
Alpha actinin-4 1.12
Alpha-2-HS-glycoprotein 1.17
Serum albumin 0.98
Protein AMBP 1.24
Angioprotein-related protein 7 1.58
Annexin A1 0.96
Annexin A2 0.9
Annexin A5 0.87
Beta-2-glycoprotein-1 1.25
Biglycan 0.95
Complement C3 1.03
Complement C4 0.97
Calmodulin 1.86*
C-C motif chemokine 5 0.96
CD44 antigen 1.63
Complement factor B 1.37
Complement factor D 1.50
Complement factor H 0.82
Chondroadherin 1.02
Chitinase-3-like protein-1 0.64*
C-type lectin domain family-3 member A 0.71
Tetranectin 1.4
Clusterin 0.59*
Collagen alpha-1(I) chain 1.08
Collagen alpha-2 (I) chain 1.09
Collagen alpha-1(II) chain 1.05
Cartilage Oligomeric Matrix Protein 0.9
Cystatin-C 1.10
Cystatin-B 2.20*
C-X-C motif chemokine-6 0.79
Acyl-CoA-binding protein 2.04*
Decorin 0.93
Dermatopontin 0.92
Alpha enolase 1.00
Ezrin 1.72*
Fibrillin-1 0.69
Fibrinogen alpha chain 0.88
Fibromodulin 1.10
Fibronectin 0.86
Follistatin-related protein-1 0.76
Gelsolin 1.31
Hyaluronan and proteoglycan link protein 1.00
Haemoglobin subunit alpha 1.12
Haemoglobin subunit beta 0.98
High mobility group protein B1 1.56
Haemopexin 1.81
Insulin-like growth factor-binding protein-4 1.00
Insulin-like growth factor-binding protein-5 0.96
Insulin-like growth factor-binding protein-6 1.28
Interleukin-6 0.5*
Insulin 1.19
Inter alpha-trypsin inhibitor heavy chain H1 0.93
Keratin type I, cytoskeletal 10 1.26
Keratin type II, cytoskeletal 7 1.25
Keratin, type II, cytoskeletal 79 3.92
Galectin-1 2.04*
Protein-lysine 6-oxidase 0.91
Lumican 1.06
Microtubule-associated protein-4 1.88*
72 kDa type IV collagenase 0.61*
Moesin 1.01
Myosin light chain 1/3, skeletal muscle isoform 1.51
Myocilin 1.28
Mimecan 0.63
Alpha-1-acid glycoprotein 1.14
Pancreactic trypsin inhibitor 1.34
Protein disulphide isomerase 1.06
Metallothionein-1 1.6*
Regakine-1 1.37
Phosphatidylethanolamine-binding protein-1 1.83*
Phosphoglycerate mutase-1 1.30
Peptidoglycan recognition protein-1 1.01
Peptidyl-polyl-cis-trans isomerase B 1.15
Peroxiredoxin-2 1.30
Retinol-binding protein-4 1.07
Reticulocalbin-3 1.2
Ribonuclease-4 1.22
Protein S100-A4 1.57
Serpin A3-2 1.18
Serpin A3-4 1.03
Antithrombin-III 1.27
Pigment epithelium-derived factor 1.32
Superoxide Dismutase 2.07
Osteopontin 1.21
Transgelin 2.91*
Serotransferrin 1.12
Thrombospondin-1 1.07
Thrombospondin-4 1.2
Metalloproteinase inhibitor-1 0.71
Metalloproteinase inhibitor-2 0.89
Thymosin beta-4 2.13*
Triosephoasphate isomerase 1.2
Tropomyosin beta chain 1.49
Tropomyosin alpha-3 chain 1.16
Transthyretin 1.01
Thioredoxin 2.06*
Polyubiquitin-B 2.90*
Versican core protein 0.9
Vimentin 1.23
Table 2. List of proteins found in physiological (LF) and degenerative (HF) media following proteomic analysis. The 
relative intensity ratio between LF/HF is shown. Significant differences in relative intensity are signified by * (p < 0.05; 
n = 4 independent media samples).
degenerative conditions on day 2, whilst for AF tissue 
there was a significant increase in expression on day 2 and 
4 under both treatments (Fig. 2a, p < 0.05). In terms of 
CXCL6 mRNA expression, there was a significant increase 
in expression within both tissues at each time point, except 
for AF LF at day 7 (Fig. 2b, p < 0.05). There was a decrease 
in CXCL12 mRNA expression within the NP LF and the 
AF at day 2, and the AF LF remained down-regulated on 
day 4 and 7 relative to day 0 (Fig. 2c, p < 0.05). Finally, 
both the CCL5 and the CXCL6 mRNA expression were 
increased (p < 0.05) in the AF compared to the NP under 
LF conditions at day 4.
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Fig. 1. Boyden chamber assessment 
of human MSC chemotactic migration 
from rais ing concentrat ions of 
physiological medium in the upper 
chamber towards 100 % degenerative 
media in the lower chamber. Basal 
migration is represented by the dotted 
line and shows cell migration with 
100 % degenerative media in both upper 
and lower chambers. LF represents 
physiological low frequency conditions; 
HF represents degenerative high 
frequency conditions. Both LF and HF 
media were collected on day 5 of IVD 
culture. Data represent mean ±SEM; 
n = 6 media from different animals; a 
p < 0.05 vs. 100 % LF in upper chamber.
Fig. 2. Relative mRNA expression of 
the chemoattractants (a) CCL5, (b) 
CXCL6 and (c) CXCL12 for the discs 
treated under physiological (NP LF 
(nucleus pulposus low frequency); AF 
LF (annulus fibrosus low frequency)) 
and degenerative (NP HF (nucleus 
pulposus high frequency); AF HF 
(annulus fibrosus high frequency)) 
conditions. Data represent median 
± IQR, n = 4-6 discs from different 
animals; a p < 0.05 vs. NP or AF day 
0; b p < 0.05 vs. NP LF at day 4.
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Fig. 3. Chemokine concentrations in individual physiological (LF-PBS) and corresponding degenerative (HF-PBS) media 
samples for the chemokines, (a) CCL5, (b) CXCL6 (n = 8) and the cytokines (c) IL-1β and (d) TNF-α (n = 6). Mean 
± S.E.M.: (a) CCL5 LF: 0.24 ±0.046 ng/mL, HF: 0.47 ±0.079 ng/mL (p = 0.026); (b) CXCL6 LF: 1.28 ±0.45 ng/mL, 
HF: 1.93 ±0.050 ng/mL; (c) IL-1β LF: 4.82 ±1.17 ng/mL, HF: 6.39 ±1.04 ng/mL; (d) TNF-α LF: 8.18 ±0.57 ng/mL, 
HF: 8.41 ±0.34 ng/mL. A trend towards higher concentrations in the degenerative media was observed. A relationship 
towards higher CCL5 in the presence of increased IL-1β concentration under degenerative conditions is shown (LF 
r = -0.03, HF r = 0.64 (p = 0.17)) (e), whilst a negative correlation can be described between CXCL6 and IL-1β (LF 
r = -0.93 (p = 0.008), HF r = -1.0 (p < 0.001)) (f). No discernible relationship was observed between TNF-α concentration 
and CCL5 (LF r = -0.14, HF r = 0.41) (g), while there was a negative trend between TNF-α and CXCL6 (LF r = -0.99 
(p < 0.001), HF r = -0.71 (p = 0.11)) (h).
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Chemokines (CCL5 and CXCL6) and inflammatory 
cytokine (IL-1β) are differentially released by 
physiological and degenerative discs
It was found that there was a higher CCL5 and CXCL6 
concentration in the degenerative compared to the 
physiological PBS media, whereby the increase in CCL5 
concentration in the degenerative medium was significant 
(LF 0.24 ±0.046 ng/mL, HF 0.47 ±0.079 ng/mL; mean 
± SEM, n = 8, p = 0.026). Figs. 3a and 3b show the 
differences in the respective concentrations of CCL5 
and CXCL6 within the physiological and corresponding 
degenerative media from discs of each single donor animal. 
The general trend described by the lines indicates an 
increase in chemokine concentration within degenerative 
media samples. IL-1β concentration was found to be higher 
in degenerative media, although there were no significant 
differences between conditions (Fig. 3c). TNF-α showed 
no such trend, and there was no difference between 
the physiological and degenerative media (Fig. 3d). 
Furthermore, correlation analysis of IL-1β and the present 
chemokines demonstrates a positive trend between IL-1β 
and CCL5 concentrations under degenerative conditions 
(LF r = -0.03, HF r = 0.64 (p = 0.17); Fig. 3e), whilst 
CXCL6 showed a significant negative correlation with 
respect the IL-1β under both conditions (LF r = -0.93 
(p = 0.008), HF r = -1.0 (p < 0.001); Fig. 3f). No clear trend 
was observed between TNF-α and CCL5 (LF r = -0.14, 
HF r = 0.41; Fig. 3g), but a negative trend was observed 
between TNF-α and CXCL6 (LF r = -0.99 (p < 0.001), HF 
r = -0.71 (p = 0.11); Fig. 3h).
CCL5 depletion decreases chemotactic activity of 
IVD conditioned media
Immunoprecipitation of either CCL5 or CXCL6 from the 
degenerative conditioned PBS media reduced their MSC 
chemo-attractive activity. When both CXCL6 and CCL5 
were immunoprecipitated out of the medium, a significant 
decrease was observed compared to the controls, consisting 
of no immunoprecipitation and beads only treatment 
(Fig. 4a; p < 0.05). Depletion of only CCL5 resulted in a 
significant decrease in chemotactic activity compared to 
the beads only control (p = 0.05) and a trend for reduced 
chemotactic activity compared to the original medium 
control (p = 0.07). There was found to be no significant 
difference between CXCL6 immunoprecipitated and the 
control samples, thereby indicating that CCL5 may be 
the main chemoattractant for MSC homing in the disc. 
Nevertheless, lowest cell migration was detected after co-
precipitation of CXCL6/CCL5 (p = 0.08 vs. CCL5 only 
precipitation), which suggests additive effects of the two 
chemoattractants.
F i g .  4 .  ( a )  B o y d e n  c h a m b e r 
assessment of chemotactic activity 
of immunoprecipitated degenerative 
conditioned PBS samples towards 
human MSCs (data represents mean 
±S.E.M; n = 6 PBS media from 
different animals; a p ≤ 0.05 vs. beads 
only treatment; b p < 0.05 vs. no 
precipitation). Data indicate that CCL5 
is a chemoattractant driving the MSC 
migration. (b) mRNA expression of 
chemokine receptors for CCL5 and 
CXCL6 in MSCs that underwent 
12 h incubation in PBS conditioned 
physiological (LF-PBS) or degenerative 
(HF-PBS) media (data represents mean 
±S.E.M; n = 4-6 PBS media from 
different animals; a p < 0.05 vs. LF-
PBS). CCL5 receptors, CCR1 and 
CCR4, had a significant increase in 
mRNA expression under degenerative 
media conditions, whilst no such 
increase was observed for CXCL6 
receptor, CXCR1, compared to MSCs 
cultured under physiological media 
conditions.
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Fig. 6. CCL5 immuno-
l a b e l l i n g  o f  h u m a n 
i n t e r v e r t e b r a l  d i s c 
sections. (a) Cluster of 
cells intensely stained for 
CCL5 in a degenerative 
human disc. (b) Negative 
control of section shown in 
(a). Single CCL5 positive 
cells in (c) AF and (d) NP 
areas of a non-degenerative 
human disc. Black arrows 
indicate CCL5 positive 
cells; white arrows indicate 
CCL5 negative cells. Scale 
bar = 20 µm.
Fig. 5. CCL5 immuno-
l a b e l l i n g  o f  b o v i n e 
i n t e r v e r t e b r a l  d i s c 
sections. (a) AF and (b) 
NP regions of discs cultured 
under degenerative (HF) 
conditions; (c) AF and (d) 
NP regions of discs cultured 
under physiological (LF) 
conditions. Black arrows 
indicate CCL5 positive 
cells; white arrows indicate 
CCL5 negative cells. Scale 
bar = 20 µm.
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IVD conditioned medium up-regulates CCL5 
chemokine receptor gene expression in MSCs
After 12 h incubation of MSCs with degenerative 
conditioned PBS medium, mRNA expression levels of 
specific chemokine receptors CCR1 and CCR4, that 
are known to bind CCL5, were significantly increased 
compared to their expression in MSCs incubated with 
physiological conditioned PBS medium (Fig. 4b; 
*p < 0.05); whilst there was no significant difference 
between PBS medium treatments for the CXCL6 receptor 
CXCR1.
CCL5 is present in bovine and human disc tissue
Cells positive for CCL5 were observed in AF and NP 
tissues of bovine discs. In both AF and NP tissues of 
discs cultured under degenerative conditions, single cells 
positively stained for CCL5 were found in proximity to 
CCL5 negative cells (Fig. 5a-b). A similar pattern was 
also observed in AF and NP tissues of discs cultured under 
physiological conditions (Fig. 5c-d).
 Immunohistochemical analysis of surgical samples 
from human degenerative discs (grade 3-4) showed clusters 
of cells intensely stained for CCL5 in the annulus fibrosus 
(Fig.6a) and single CCL5 positive cells in the nucleus 
pulposus region (in 3/3 patients). In the non-degenerative 
disc samples (grade 1-2), few single cells positive for CCL5 
were observed in the annulus fibrosus of all sections (Fig. 
6c); single positive cells were also detected in the nucleus 
pulposus area in 2/4 patients (Fig. 6d).
Discussion
The present study sought to identify the chemoattractant(s) 
that may activate MSC migration towards induced 
degenerative IVDs for the purpose of tissue regeneration. 
Two specific chemoattractants were identified within IVD 
conditioned media following proteomic analysis: CXCL6 
and CCL5. Immunoprecipitation of the chemoattractants 
from the conditioned degenerative medium demonstrated 
that CCL5 may have a role in MSC recruitment in the 
disc (Fig. 4a), although there may be an additive effect 
for both chemoattractants. Furthermore, the increased 
concentration of CCL5, among other cytokines, in the 
degenerative media may have enhanced the mRNA 
expression of CCL5-specific chemokine receptors in the 
MSCs (Fig. 4b), supporting the hypothesis that CCL5 
may be the main MSC chemoattractant in degenerative 
discs. The positive trend between high IL-1β and CCL5 
concentrations within the degenerative conditioned media 
(Fig. 3e) reinforces the concepts of previous investigations, 
whereby secretion of cytokines increased the migration 
potential of MSCs towards chemoattractants. Previous 
studies have demonstrated CCL5 to be more potent for 
chemotactic migration of MSCs upon MSC treatment with 
inflammatory cytokines such as TNFα and IL-1β (Ponte et 
al., 2007; Baek et al., 2011). CCL5 was originally identified 
as a product of activated T cells (Schall et al., 1988). It 
mediates the chemotactic activity of various cell types 
including monocytes, lymphocytes, dendritic cells, and is 
involved in wound healing processes (Martins-Green et 
al., 2013). Apart from its function as a chemokine, CCL5 
has also been reported to be involved in inflammatory 
diseases such as rheumatoid arthritis and atherosclerosis 
and has recently been identified as a factor to suppress HIV 
progression (Boiardi et al., 1999; Zernecke et al., 2008; 
Jones et al., 2011; Secchi et al., 2012).
 Studies investigating cellular migration into tissue have 
identified SDF-1α/CXCL12 as a model chemoattractant 
due to its strong chemotactic effect for MSCs, although it 
remains unknown whether this is a primary chemoattractant 
in an in vivo or ex vivo system (Ponte et al., 2007; Baek et 
al., 2011). In fact, our observation that gene expression of 
CXCL12 demonstrated no up-regulation with respect to 
day 0 shows that this may not be the primary chemokine 
that is naturally regulated in the disc (Fig. 2c). In the 
present investigation, the chemokines CXCL6 and CCL5 
were found to be produced by induced degenerative discs 
(Fig. 3a,b). The difference compared to many previous 
chemotactic investigations is that the present study was 
performed using an ex vivo system, whilst others have 
utilised a trans-well system to understand the migration 
with exogenous inflammatory cytokines applied to the 
cells.
 In in vitro studies, Baek et al. and Ponte et al. 
demonstrated that priming MSCs with TNF-α helped to 
increase their migration towards specific chemokines, 
CCL5 and CXCL12 (Ponte et al., 2007; Baek et al., 2011). 
The use of TNF-α may replicate in vivo tissue degeneration, 
as its production is one of the first steps in this process 
(Martel-Pelletier et al., 1999; Hoyland et al., 2008; Kapoor 
et al., 2011). Similarly, the use of our bioreactor system 
allows for the generation of degenerative discs mimicking 
in vivo conditions (Illien-Junger et al., 2012). Indeed, we 
have also found the presence of TNF-α and IL-1β in the 
conditioned media, indicating an inflammatory response. 
Sample medium showed an increase in IL-1β concentration 
by the degenerative discs within our system, whereas there 
was no marked up-regulation in TNF-α concentration 
(Fig. 3c,d). This correlates with previous investigations, 
whereby in human IVDs, it is suggested that IL-1β rather 
than TNF-α is involved in degeneration mechanisms (Le 
Maitre et al., 2005; Le Maitre et al., 2007; Hoyland et 
al., 2008). It should be noted that besides the tendency 
for increased IL-1β concentration, there appeared to 
be a positive trend between the concentration of IL-
1β and CCL5 in the degenerative media samples (Fig. 
3e). Furthermore, Kepler et al. recently demonstrated a 
significant positive correlation in the relationship between 
IL-1β and CCL5 within human annulus fibrosus tissue from 
painful discs (Kepler et al., 2013). These findings suggest 
that production of inflammatory cytokines by the tissue 
may correspond to an increase in chemokine production, 
in particular CCL5. The production of inflammatory 
cytokines may enable chemokine receptors on MSCs to be 
more responsive to chemokines produced by the tissue and 
therefore induce greater cell migration, particularly under 
degenerative conditions. However, it has also been shown 
that release of cytokines, particularly IL-1β, can induce 
release of specific chemokines from MSCs and therefore 
may facilitate their homing into the tissue (Carrero et al., 
2012).
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 Facilitating MSC migration are the specific chemokine 
receptors that are expressed on the cells. Honczarenko et 
al. described the presence of a set of functional receptors 
on MSCs: CCR1, CCR7, CCR9, CXCR4, CXCR5 and 
CXCR6 were found to be expressed on human bone 
marrow derived MSCs (Honczarenko et al., 2006). Upon 
stimulation with CCL5, CCR1 activated specific pathways 
within the MSCs that enabled the migration process to occur 
(Honczarenko et al., 2006). In the present investigation, 
CCR1 and CCR4 chemokine receptors associated with the 
CCL5 chemokine showed an increased mRNA expression 
in MSCs upon treatment with the degenerative media, and 
thus the presence of IL-1β and CCL5 in the media may 
have helped to facilitate MSC migration within our present 
system (Fig. 4b). Furthermore, the recent study by Kepler et 
al. using human annulus fibrosus cells suggests that CCR1 
may be the primary receptor for CCL5 binding interaction 
(Kepler et al., 2013).
 The present study investigated the specific 
chemoattractants for MSC recruitment that would 
enable tissue regeneration in the disc, although a recent 
investigation has shown that the stimulation of rat 
nucleus pulposus cells with TNF-α and IL-1β induced 
the production of another chemokine, macrophage 
inflammatory protein-1 alpha (MIP-1α/CCL3). The 
chemokine enables the migration of macrophages in the 
degenerative herniated disc tissue that would help prevent 
further degeneration, through removal of apoptotic cells 
by phagocytosis (Wang et al., 2013). This complements 
the present investigation in that we show a possible 
MSC-based regeneration pathway, alongside a pathway 
for preventing further degeneration. Interestingly, CCR1 
is also a chemokine receptor for MIP-1α/CCL3; so the 
pathways may be inter-linked and CCL5 may also interact 
with its other receptors, e.g., CCR4. It should be noted 
that chemokine receptors are binding sites for various 
chemokines rather than being specific to one chemokine. 
Nevertheless, what can be ascertained from both studies 
is that the presence of the inflammatory cytokines and 
chemokines facilitates the homing process and therefore 
an inter-link can be established based on the secretion of 
both sets of factors, whereby secretion of the cytokine 
increases the responsiveness of MSCs towards the specific 
chemoattractants, as demonstrated by the MSC priming 
study using physiological and degenerative conditioned 
media (Fig. 4b). Furthermore, recent work has shown that 
CXCL10 is able to recruit human annulus fibrosus cells 
and thus migration may also occur among native cells 
within the IVD tissues (Hegewald et al., 2012). Finally, the 
present investigation shows intense CCL5 expression at the 
protein level in clusters of cells in human degenerative disc 
tissue (Fig. 6). This observation basically supports previous 
findings on CCL5 mRNA expression, which was found to 
increase with increasing grade of disc degeneration (Kepler 
et al., 2013).
 In the context of disc regeneration, the described 
cytokines or chemokines may be used within a delivery 
system, whereby the controlled release of these factors 
would help facilitate cell homing into the degenerating 
disc (Goncalves et al., 2012). MSCs may then be recruited 
from adjacent tissue and migrate to the disc, as has been 
described in recent in vivo homing studies for both cartilage 
and bone (Lee et al., 2010a; Mokbel et al., 2011; Seol et 
al., 2012; Song et al., 2013). This represents an alternative 
form for regenerating tissues. However, resident nucleus 
pulposus or annulus fibrosus progenitor cell populations 
that are present in distinct niches within the disc may 
also be mobilised to the site of damage and facilitate the 
regeneration process (Risbud et al., 2007; Sakai et al., 
2012). Furthermore, different chemokines may facilitate 
homing of cells for nucleus pulposus and annulus fibrosus 
repair, although this requires further investigation.
 The model described in the present study has been 
validated in previous work (Illien-Junger et al., 2010; 
Illien-Junger et al., 2012). However, certain limitations 
need to be taken into consideration when comparing it to 
the situation in human disc degeneration. In particular, our 
model can simulate a degenerative state on the cellular 
level, while changes on the extracellular matrix level 
cannot be clearly observed (Illien-Junger et al., 2010). 
The reasons for this imply the relatively young age of the 
animals and the short term culture of the discs.
Conclusions
Our findings indicate that CCL5 is produced and secreted 
by the intervertebral disc cells and its release is increased 
in response to degenerative conditions. Medium from 
degenerative discs shows a chemotactic effect on human 
MSCs. Furthermore, this chemotactic effect is strongly 
reduced by immunoprecipitation of CCL5 and to a 
lesser extent of CXCL6 from the degenerative medium. 
These findings suggest that CCL5 may be the main 
chemoattractant released by degenerating discs. Therefore, 
these factors could be used to enhance stem/progenitor 
cell mobilisation in regenerative therapies for early stages 
of disc degeneration. However, additional studies will be 
required to confirm the role of these chemokines for cell 
stimulation in vivo under induced and native degenerative 
disc conditions.
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Discussion with Reviewer
Nam Vo: Could you speculate a bit further on how 
chemoattractants such as CCL5 could be adapted into a 
therapy for painful disc degeneration?
Authors: It is conceivable that early stages of painful 
disc degeneration with insufficient response to 
conservative treatment may be addressed by application 
of chemoattractants. The hypothesis would be that the 
chemoattractant would accelerate the endogenous repair 
response by enhancing recruitment of regenerative 
stem cells. The roles of recruited cells involve their 
differentiation, as well as anabolic and anti-inflammatory 
trophic effects. These effects are suggested to reduce pain, 
since both structural failure and inflammatory processes are 
known to contribute to painful disc degeneration.
 Proof-of-concept studies of induced stem cell 
recruitment have successfully been performed in cartilage 
repair, using biomaterial scaffolds loaded with chemokines. 
For IVD repair, injectable hydrogels may be more attractive 
for chemoattractant delivery. Moreover, if an annular 
defect is implied, an appropriate annular closure system 
will need to be provided to ensure effective repair. Further 
organ culture and in vivo studies will be necessary to assess 
the regenerative effects of chemokine delivery in early 
degenerative discs.
